P559: Efficacy of Ustekinumab in the treatment of patients with Crohn’s disease with failure to previous conventional or biologic therapy: an observational real-life studyECCO'21 VirtualYear: 2021
Authors: Miranda, A.(1);Cuomo, A.(2);Camera, S.(2);Ciacci, C.(3);De Filippo, F.R.(3);Gravina, A.G.(1);D'Onofrio, V.(4);Melina , R.(4);Manguso, F.(5);PRIADKO, K.(1);Facchiano, A.(1);Bennato, R.(6);D'Onofrio, R.(1);Cuomo, R.(7);Mucherino, C.(8);Romano, M.(1);
(1)Università degli Studi della Campania 'L. Vanvitelli', Department of Precision Medicine and Endoscopy Unit, Napoli, Italy;(2)Umberto I Nocera Inferiore, U.O.C. of Gastroenterology, Nocera Inferiore, Italy;(3)University Hospital San Giovanni di Dio e Ruggi D'Aragona, U.O.C. of Gastroenterology, Salerno, Italy;(4)San Giuseppe Moscati Avellino Hospital, U.O.C. of Gastroenterology, Avellino, Italy;(5)A. Cardarelli Hospital, U.O.C. of Gastroenterology, Napoli, Italy;(6)A. Cardarelli Hospital, U.O.C. of Gastroenterology, Naples, Italy;(7)Sant'Anna and San Sebastiano Hospital, U.O.C of Gastroenterology, Caserta, Italy;(8)Caserta Hospital, U.O.C. of Gastroenterology, Caserta, Italy
P560: Clinical outcomes of vedolizumab maintenance treatment for Korean patients with inflammatory bowel disease who failed anti-TNF therapy: A KASID prospective multicenter cohort studyECCO'21 VirtualYear: 2021
Authors: Oh, K.(1);Kim, J.(2);Kim, N.(3);Yoon, H.(4);Lee, K.M.(5);Park, D.I.(6);Choi, C.H.(7);Lee, C.K.(8);Eun, C.S.(9);Kang, S.B.(10);Kim, E.S.(11);Kim, Y.S.(12);Jung, S.A.(13);Jung, Y.(14);Kim, T.O.(15);Park, S.J.(16);Im, J.P.(17);Seo, G.S.(18);Ye, B.D.(19);
(1)University of Ulsan College of Medicine- Asan Medical Center, Gastroenterology, Seoul, Korea- Republic Of;(2)Keimyung University School of Medicine, Internal Medicine, Daegu, Korea- Republic Of;(3)Asan Medical Center, Biostatistics and Clinical Epidemiology, Seoul, Korea- Republic Of;(4)Seoul National University Bundang Hospital, Internal Medicine, Seongnam, Korea- Republic Of;(5)St. Vincent's Hospital- College of Medicine- The Catholic University of Korea, Internal Medicine, Seoul, Korea- Republic Of;(6)Kangbuk Samsung Hospital- Sungkyunkwan University School of Medicine, Internal Medicine, Seoul, Korea- Republic Of;(7)Chung-Ang University College of Medicine, Internal Medicine, Seoul, Korea- Republic Of;(8)Kyung Hee University College of Medicine, Gastroenterology, Seoul, Korea- Republic Of;(9)Hanyang University Guri Hospital, Internal Medicine, Guri, Korea- Republic Of;(10)Daejeon St. Mary's Hospital- College of Medicine- The Catholic University of Korea, Internal Medicine, Daejeon, Korea- Republic Of;(11)Kyungpook National University- School of Medicine, Internal Medicine, Daegu, Korea- Republic Of;(12)Seoul Paik Hospital- Inje University College of Medicine, Internal Medicine, Seoul, Korea- Republic Of;(13)Ewha Womans University School of Medicine, Internal Medicine, Seoul, Korea- Republic Of;(14)Soonchunhyang University College of Medicine, Medicine, Cheonan, Korea- Republic Of;(15)Haeundae Paik Hospital- Inje University College of Medicine, Internal Medicine, Busan, Korea- Republic Of;(16)Severance Hospital- Yonsei University College of Medicine, Internal Medicine and Institute of Gastroenterology, Seoul, Korea- Republic Of;(17)Seoul National University College of Medicine, Internal Medicine and Liver Research Institute, Seoul, Korea- Republic Of;(18)Wonkwang University School of Medicine, Internal Medicine, Iksan, Korea- Republic Of;(19)University of Ulsan College of Medicine- Asan Medical Center, Gastroenterology and Inflammatory Bowel Disease Center, Seoul, Korea- Republic Of; IBD Research Group of the Korean Association for the Study of Intestinal Diseases
P563: Comparison of long-term outcomes of infliximab with adalimumab in biologic naïve patients with Crohn’s disease: a tertiary referral center 13-year experience.ECCO'21 VirtualYear: 2021
Authors: Yuksel, I.(1,2);Durak, M.B.(2);Kilic, V.(2);Kivrakoglu, F.(1,2);Kosar, K.(2);Erdogan, C.(2);Alkan, A.(3);
(1)Ankara Yildirim Beyazit University School of Medicine., Department of Gastroenterology., Ankara, Turkey;(2)Ankara City Hospital., Department of Gastroenterology, Ankara, Turkey;(3)Ankara Yildirim Beyazit University School of Medicine, Department of Biostatistics and Medical Informatics, Ankara, Turkey
P564: Validation of the IBD-Disk instrument in a Portuguese cohortECCO'21 VirtualYear: 2021
Authors: Silva Mendes, S.(1,2);Ferreira, P.(2);Antunes, P.(1);Gonçalves, M.(1);Leal, T.(1);Gonçalves, B.(1);Rebelo, A.(1);Arroja, B.(1);Caetano, A.C.(1,2);Gonçalves, R.(1);Soares, J.B.(1);
(1)Braga Hospital, Gastroenterology, Braga, Portugal;(2)University of Minho, Life and Health Sciences Research Institute ICVS- School of Medicine, Braga, Portugal
P565: Illness perception as a clinical tool to detect mood disturbances (anxiety or depression) in inflammatory bowel disease patients.ECCO'21 VirtualYear: 2021
Authors: De Castro Parga, M.L.(1,2);Pereyra, D.(1);Sanromán, L.(1);Figueira, M.(1);Hernández, V.(1);Pineda, J.(1);Martinez-Cadilla, J.(1);Pereira, S.(1);Rodriguez-Prada, J.I.(1);
(1)University Hospital Complex of Vigo, Department of Gastroenterology, Vigo, Spain;(2)Instituto de Investigación Sanitaria Galicia Sur IIS Galicia Sur., Sergas, Vigo, Spain
P566: Impact of induction therapy and clinical remission on resting energy expenditure in children with Crohn’s DiseaseECCO'21 VirtualYear: 2021
Authors: Kornitzer, G.(1);Breton, J.(2);Poinsot, P.(3);Godin, D.(4);Grzywacz, K.(1);Deslandres, C.(1);Groleau, V.(1);
(1)Sainte-Justine University Hospital Center, Department of Paediatrics - Division of Gastroenterology- Hepatology and Nutrition, Montreal, Canada;(2)Children's Hospital of Philadelphia, Division of Gastroenterology- Hepatology and Nutrition and Center for Pediatric Inflammatory Bowel Disease, Philadelphia, United States;(3)Hospices Civils de Lyon, Service de gastroentérologie- hépatologie et nutrition pédiatriques, Lyon, France;(4)Sainte-Justine University Hospital Center, Division of Gastroenterology- Hepatology and Nutrition, Montreal, Canada
P567: Pharmacist-managed immunomodulator clinic in titration and monitoring of immunosuppressants in Inflammatory Bowel DiseaseECCO'21 VirtualYear: 2021
Authors: Ng, V.(1);Lim, T.G.(1,2);Ong, W.C.(1);Wong, S.Y.A.(1);Salazar, E.(3);Chan, P.W.W.(2,3);
(1)Singapore General Hospital- Singapore, Pharmacy, Singapore, Singapore;(2)Duke-NUS Medical School, Medicine, Singapore, Singapore;(3)Singapore General Hospital- Singapore, Gastroenterology and Hepatology, Singapore, Singapore
P568: Effectiveness of ustekinumab after vedolizumab failure in patients with anti-TNF-refractory Crohn’s disease.ECCO'21 VirtualYear: 2021
Authors: Dussias, N.(1);Rizzello, F.(1);Calabrese, C.(1);Sanna Passino, A.(1);Melotti, L.(1);Scaioli, E.(1);Belluzzi, A.(1);Gionchetti, P.(1);
(1)University of Bologna, Dept. of surgical and medical sciences, Bologna, Italy
P570: Prediction of achieving remission in Crohn's disease patients by abdominal ImagingECCO'21 VirtualYear: 2021
Authors: Meringer, H.(1);Tzadok, R.(1);Mercer, D.(2);Handler, M.(2);Barnes, S.(2);Waterman, M.(3);Abadi, S.(4);Margalit Yehuda, R.(5);Kopylov, U.(5);Amitai, M.M.(6);Bar-Gil Shitrit, A.(7);Sheynkman, G.(8);Zittan, E.(9);Maharshak, N.(1);
(1)Tel Aviv Sourasky Medical Center and Sackler School of Medicine- Tel Aviv University, Department of Gastroenterology and Liver Diseases, Tel Aviv, Israel;(2)Tel Aviv Sourasky Medical Center and Sackler School of Medicine- Tel Aviv University, Department of Radiology, Tel Aviv, Israel;(3)Rambam Health Care Campus, Department of Gastroenterology, Haifa, Israel;(4)Rambam Health Care Campus, Department of Radiology, Haifa, Israel;(5)Sheba Medical Center and Sackler School of Medicine- Tel Aviv University, Division of Gastroenterology, Ramat Gan, Israel;(6)Sheba Medical Center, Department of Radiology, Ramat Gan, Israel;(7)Faculty of Medicine- Hebrew University of Jerusalem, IBD MOM Unit- Digestive Diseases Institute- Shaare Zedek Medical Center, Jerusalem, Israel;(8)Shaare Zedek Medical Center, Department of Radiology, Jerusalem, Israel;(9)Institute of Gastroenterology and Liver Diseases, IBD Unit- Emek Medical Center, Afula, Israel
P571: Optimal biologic management of endoscopic postoperative recurrence following ileocecal resection in Crohn’s diseaseECCO'21 VirtualYear: 2021
Authors: Bachour, S.(1);Shah, R.(1);Lyu, R.(2);Rieder, F.(1);Cohen, B.(1);Qazi, T.(1);Lashner, B.(1);Achkar, J.P.(1);Philpott, J.(1);Lightner, A.(3);Holubar, S.(3);Regueiro, M.(1);Click , B.(1);
(1)Cleveland Clinic Foundation, Department of Gastroenterology and Hepatology, Cleveland, United States;(2)Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Cleveland, United States;(3)Cleveland Clinic Foundation, Department of Colorectal Surgery, Cleveland, United States
P572: The influence of beliefs about medication in therapeutic adherence among patients with inflammatory bowel disease.ECCO'21 VirtualYear: 2021
Authors: De Castro Parga, M.L.(1,2);Alvarez-Smith, C.(1);Sanroman, L.(1);Figueira, M.(1);Hernández, V.(1);Pineda, J.(1);Martinez-Cadilla, J.(1);Pereira, S.(1);Rodriguez-Prada, I.(1);
(1)University Hospital Complex of Vigo, Department of Gastroenterology, Vigo, Spain;(2)Instituto de Investigación Sanitaria Galicia Sur IIS Galicia Sur., Sergas, Vigo, Spain
P573: Comparative effectiveness of second-line biological therapies for Ulcerative colitis and Crohn’s disease in patients with prior failure of anti-tumour necrosis factor treatmentECCO'21 VirtualYear: 2021
Authors: Hyun, H.K.(1);Yu, J.(1);Kang, E.A.(1);Park, J.(1);Park, S.J.(1);Park, J.J.(1);Kim, T.I.(1);Kim, W.H.(1);Cheon, J.H.(1);
(1)Yonsei University College of Medicine, Gastroenterology, Seoul, Korea- Republic Of
P574: Exploring treatment of Crohn’s disease and ulcerative colitis in the Middle East and Northern Africa: An analysis of the HARIR observational cohort studyECCO'21 VirtualYear: 2021
Authors: Hamed, W.(1);Salem, O.E.(2);Alharbi, O.(3);,4;Sharaf, M.(5);Taylor, C.(6);Sherief, A.(7);Besar, A.(6);
(1)Ain Shams University Hospital, Department of Tropical Medicine, Cairo, Egypt;(2)Osama Ebada GI Center, Department of Internal Medicine, Alexandria, Egypt;(3)King Saud University, College of Medicine, Riyadh, Saudi Arabia;(4)King Khalid University Hospital, College of Medicine, Riyadh, Saudi Arabia;(5)Janssen, Medical Affairs, Jeddah, Saudi Arabia;(6)Janssen, Medical Affairs, Dubai, United Arab Emirates;(7)Janssen, Medical Affairs, Cairo, Egypt
P575: Nutrition and Inflammatory Bowel Disease – a nationwide survey of patients, gastroenterologists and dietitiansECCO'21 VirtualYear: 2021
Authors: McCarthy, N.(1);Schultz, M.(2);Wall, C.(1);
(1)University of Otago- Christchurch, Department of Medicine, Christchurch, New Zealand;(2)University of Otago, Department of Medicine, Dunedin, New Zealand
P576: Ustekinumab levels correlate with induction fecal calprotectin drop-slope and discriminate the need for intensification at week 52 in Crohn's Disease patients.ECCO'21 VirtualYear: 2021
Authors: Mateos, B.(1);Sáez-González, E.(2);Iborra, M.(2);Moret, I.(1);Cañada, A.(3);Tortosa, L.(1);Bastida, G.(2);Aguas, M.(2);Cerrillo, E.(2);Nos, P.(2);Beltrán, B.(2);
(1)Health Research Institute La Fe, Inflammatory Bowel Disease, Valencia, Spain;(2)La Fe Hospital, Gastroenterology, Valencia, Spain;(3)Health Research Institute La Fe, Biostatistics, Valencia, Spain